Nagpur: The Central Board of Secondary Education (CBSE) has issued a strict advisory ahead of the 2026 Class 10 board ...
Bioptimus, the leader in AI models for biology, today announced a major leap forward with the unveiling of M-Optimus, the first model that combines multiple biological modalities, designed to simulate ...
Strangio’s softening rhetoric about the goals of the transgender movement comes at a critical juncture for the ACLU, whose ...
The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...
A senior oncologist explains why in India, where the cancer burden continues to rise, these advancements carry heightened ...
Arcellx (ACLX) is positioned to disrupt multiple myeloma cell therapy with anito-cel, leveraging superior efficacy, safety, ...
The Canadian Press on MSN
World of woes: How the global polycrisis is shaping Canada's youth
The World Happiness Report suggests young people have become Canada's unhappiest age group, a complete reversal of long-standing trends. As recently as 2011, those under 30 were the happiest ...
Having not one, not two, but three large animal veterinarians in my extended family, and understanding the vital role these rural vets play in helping preserve the nation’s farms and ranches, my ears ...
US FDA approves AstraZeneca and Daiichi Sankyo’s Enhertu plus pertuzumab for 1st-line treatment of patients with HER2-positive metastatic breast cancer: Cambridge, UK Wednesday, ...
Animalogic on MSN
How pigeons decode environmental clues that humans barely notice
This video investigates the biological and environmental tools pigeons use to navigate home over long distances. Scientists ...
Washington Research Foundation (WRF) has awarded three-year postdoctoral fellowships to a new cohort of 12 early-career researchers who will pursue innovative, high-impact projects in the natural ...
The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results